TIAA CREF Trust’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$9.3M Buy
78,460
+4,123
+6% +$467K 0.07% 101
2016
Q4
$7.45M Buy
74,337
+2,521
+4% +$270K 0.06% 115
2016
Q3
$9.07M Buy
71,816
+1,188
+2% +$147K 0.08% 100
2016
Q2
$8.26M Buy
70,628
+6,326
+10% +$716K 0.08% 103
2016
Q1
$6.66M Buy
64,302
+43,220
+205% +$4.18M 0.07% 118
2015
Q4
$2.1M Buy
21,082
+1,130
+6% +$111K 0.02% 177
2015
Q3
$1.82M Sell
19,952
-1,726
-8% -$173K 0.02% 179
2015
Q2
$2.3M Buy
21,678
+890
+4% +$98.5K 0.03% 171
2015
Q1
$2.37M Sell
20,788
-147
-0.7% -$16.8K 0.03% 172
2014
Q4
$2.31M Buy
20,935
+2,988
+17% +$315K 0.03% 172
2014
Q3
$1.75M Buy
17,947
+1,404
+8% +$138K 0.02% 180
2014
Q2
$1.67M Buy
16,543
+696
+4% +$67.9K 0.02% 183
2014
Q1
$1.46M Sell
15,847
-864
-5% -$79.6K 0.02% 186
2013
Q4
$1.51M Buy
16,711
+1,496
+10% +$129K 0.03% 181
2013
Q3
$1.21M Sell
15,215
-2,814
-16% -$222K 0.02% 177
2013
Q2
$1.31M Buy
+18,029
New +$1.35M 0.03% 173

Other funds holding ZBH

TIAA CREF Trust's ZBH Position: Q1 2017 in Review

TIAA CREF Trust increased its Zimmer Biomet (ZBH) stake by 5.5% in Q1 2017, buying an estimated $467K and bringing the position to 78,460 shares worth $9.3M. The position accounts for 0.07% of the portfolio, ranked #101.

TIAA CREF Trust first reported a position in ZBH in Q2 2013 and has held it in 16 quarters since. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

  • TIAA CREF Trust held 78,460 shares of Zimmer Biomet worth $9.3M as of Q1 2017.
  • TIAA CREF Trust bought 4,123 Zimmer Biomet shares in Q1 2017, an estimated $467K.
  • Zimmer Biomet made up 0.07% of TIAA CREF Trust's portfolio in Q1 2017, its #101 holding.
  • TIAA CREF Trust first reported a position in Zimmer Biomet in Q2 2013 and has held it in 16 quarters since.
  • 817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.